ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1865

Improving Lupus Care Index Documentation in Patients with Childhood-Onset Systemic Lupus Erythematosus (cSLE)

Fatima Barbar-Smiley1, Stephanie Lemle 1, Cagri Yildirim-Toruner 1, Edward Oberle 1, Darby McDonald 1, Vidya Sivaraman 2 and Stacy Ardoin 1, 1Nationwide Children's Hospital, Columbus, OH, 2Nationwide Children's Hospital and The Ohio State University, Columbus, OH

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Disease Activity, juvenile SLE and activity score, quality improvement, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: 4M112: Measures of Healthcare Quality I: Digital Health Technologies – Tool for Improvement (1860–1865)

Session Type: ACR Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Systemic lupus erythematosus (SLE) affects both adults and children with an estimated prevalence in children of 8/100,000. More than 1000 deaths related to SLE occur in a 5-year period, with most common causes attributed to active disease and organ failure.  Adequate control of the disease reduces risk of organ damage, which is more common in children. Reliable measurement and documentation of disease activity is a key initial step for disease control. To achieve proper documentation of disease activity, our team developed a disease activity assessment tool called the Lupus Care Index (LCI). This index utilizes three existing metrics: SLE disease activity index (SLEDAI), Physician global assessment (PGA), and patient pain score.  At our institution, we found that only one third of children diagnosed with SLE (cSLE) had proper documentation of all three components of LCI.  We implemented a quality improvement (QI) project with aim to increase Lupus Care Index documentation, in children with SLE, from 38 % to 80%, by June 30, 2018.

Methods: We established a QI team including physicians, nurses, QI support staff. Patients with cSLE who received medical care in the pediatric rheumatology clinic from January 1, 2016 to November 31, 2016 were included in the baseline analysis.  We excluded clinic visits scheduled for teaching purposes. Our process included a brainstorming session followed by development of a key driver diagram (Fig. 1). Our first PDSA cycle focused on establishing requirements for LCI and a team consensus for proper documentation. Next, we created a Pareto chart to assist with a targeted intervention approach focusing on least documented indices (Fig. 2).  We ran monthly reports and provided timely feedback to providers, and developed EHR (electronic health medical record; EPIC) “soft stop” reminders for physicians to document disease activity prior to closing clinic encounters.  We utilized control charts to show the monthly percentage of c-SLE patients who had complete documentation of all three components of LCI (Fig. 3).

Results: We noted initial improvement trend in documentation with project awareness, score standardization, and provider level monthly feedback. However, we were able to achieve and surpass our goal of 80% in Aug 2018 after establishing the EHR soft stop reminder. We have sustained the desired improvement for 8 months.

Conclusion: The results of this quality improvement initiative highlight the role of EHR reminders along with provider feedback and transparency in promoting quality of health care delivery. Future directions of this project aim at utilizing the documented disease activity indices to reduce disease activity and improve patient disease outcomes.

Fig.1 Key Driver Diagram -KDD-

Fig. 2 Pareto Chart

Fig 3. Control Chart


Disclosure: F. Barbar-Smiley, None; S. Lemle, None; C. Yildirim-Toruner, None; E. Oberle, None; D. McDonald, None; V. Sivaraman, None; S. Ardoin, None.

To cite this abstract in AMA style:

Barbar-Smiley F, Lemle S, Yildirim-Toruner C, Oberle E, McDonald D, Sivaraman V, Ardoin S. Improving Lupus Care Index Documentation in Patients with Childhood-Onset Systemic Lupus Erythematosus (cSLE) [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/improving-lupus-care-index-documentation-in-patients-with-childhood-onset-systemic-lupus-erythematosus-csle/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-lupus-care-index-documentation-in-patients-with-childhood-onset-systemic-lupus-erythematosus-csle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology